Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

402
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
402
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

289
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
289
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

990
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
990
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

875
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
875
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

449
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
449
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

448
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
448

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[ChatGPT and the German board examination for ophthalmology: an evaluation].

Die Ophthalmologie·2024
Same author

[Diagnostics and treatment of ocular toxoplasmosis : Results of a survey].

Die Ophthalmologie·2022
Same author

Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations.

International journal of retina and vitreous·2022
Same author

[Are "pachychoroid spectrum disorders" a topic for CME?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

[Intraocular inflammation with brolucizumab use : Patient management-diagnosis-therapy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

[Red eye somewhat different : From local finding to systemic diagnosis].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020

Related Experiment Video

Updated: Mar 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K

[Scleritis - Progress in Diagnosis and Therapy].

D Pohlmann1, U Pleyer1

  • 1Universitäts-Augenklinik, Charité Campus Virchow-Klinik, Berlin.

Klinische Monatsblatter Fur Augenheilkunde
|February 14, 2017
PubMed
Summary
This summary is machine-generated.

Scleritis, an inflammation of the sclera, can cause severe vision complications and is often linked to systemic diseases. This review covers its differential diagnosis and current treatment strategies.

More Related Videos

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.4K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.9K

Related Experiment Videos

Last Updated: Mar 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.0K
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.4K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.9K

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Scleral inflammation encompasses diverse morphological changes, frequently associated with systemic conditions.
  • Episcleritis is typically benign, whereas scleritis can be destructive.
  • Scleritis may lead to severe ocular complications like ulcerative keratitis, uveitis, and secondary glaucoma.

Purpose of the Study:

  • To provide a comprehensive overview of the differential diagnosis of scleral inflammation.
  • To discuss current therapeutic approaches for managing scleritis.
  • To highlight the association between scleritis and underlying systemic diseases.

Main Methods:

  • Literature review of scleral inflammation, focusing on diagnostic criteria.
  • Analysis of current treatment modalities for various forms of scleritis.
  • Emphasis on the importance of identifying and managing associated systemic conditions.

Main Results:

  • Scleritis presents a diagnostic challenge due to its varied manifestations.
  • Effective management requires a multidisciplinary approach, addressing both ocular and systemic factors.
  • Early diagnosis and treatment are crucial to prevent vision loss and systemic complications.

Conclusions:

  • Scleritis is a severe inflammatory condition requiring prompt and accurate diagnosis.
  • Treatment strategies should be tailored to the underlying cause and disease activity.
  • Integrated management involving ophthalmologists and other specialists is essential for optimal patient outcomes.